Drug therapy. Therapies create opportunities for companies to do a new waypharmacogenomics, the study of the genetic variability in the way people respond to medicines, the potential to make an important, technology-driven restructuring of the healthcare and pharmaceutical industry sparks according to a commentary published in the latest issue of Nature Medicine by faculty of Indiana University Program in pharmacogenomics, Ethics and Public Policy.
The American Journal of Preventive Medicine is the 14th 99 Public, Environmental & Occupational Health titles and 16th of 105 General and Internal Medicine titles ranked by the Thomson Scientific Institute for Scientific Information ‘s 2005 Journal Citation Reports.By courtesy of to can all Kaiser Daily Health Policy show Reports, search the archives or sign up for email notification in Kaiser Daily Health Policy Report press for royal network the complimentary. Repair by The Henry J. Released. Kaiser Family Foundation.